blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1493437

EP1493437 - COMPOSITIONS FOR DIABETES [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  24.09.2010
Database last updated on 19.07.2024
Most recent event   Tooltip24.09.2010Withdrawal of applicationpublished on 27.10.2010  [2010/43]
Applicant(s)For all designated states
KANEKA CORPORATION
2-4, Nakanoshima 3-chome
Kita-ku
Osaka-shi, Osaka 530-8288 / JP
[N/P]
Former [2005/01]For all designated states
KANEKA CORPORATION
2-4, Nakanoshima 3-chome, Kita-ku
Osaka-shi, Osaka 530-8288 / JP
Inventor(s)01 / FUJII, Kenji
5-11, Hanayamanakaodai 2-chome, Kita-ku
Kobe-shi, Hyogo 651-1202 / JP
02 / KAWABE, Taizo
7-203, Shimonoda 1-chome, Shikama-ku
Himeji-shi, Hyogo 672-8044 / JP
03 / HOSOE, Kazunori
8-17, Nishihata 3-chome
Takasago-shi, Hyogo 676-0025 / JP
04 / HIDAKA, Takayoshi
21-8, Hontamon 2-chome, Tarumi-ku
Kobe-shi, Hyogo 655-0006 / JP
 [2005/01]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2005/01]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date03712784.220.03.2003
[2005/01]
WO2003JP03389
Priority number, dateJP2002007790920.03.2002         Original published format: JP 2002077909
[2005/01]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03077895
Date:25.09.2003
Language:EN
[2003/39]
Type: A1 Application with search report 
No.:EP1493437
Date:05.01.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 25.09.2003 takes the place of the publication of the European patent application.
[2005/01]
Search report(s)International search report - published on:JP25.09.2003
(Supplementary) European search report - dispatched on:EP08.07.2010
ClassificationIPC:A61K31/09, A61K31/122, A61K45/00, A61P3/10, A23L1/00, A23K1/00
[2005/01]
CPC:
A61K31/09 (EP,KR,US); A23K20/111 (EP,US); A23L33/10 (EP,US);
A23L33/40 (EP,US); A61K31/122 (EP,KR,US); A61P3/10 (EP);
A61P43/00 (EP); A23V2002/00 (EP,US) (-)
C-Set:
A23V2002/00, A23V2250/314 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
TitleGerman:ZUSAMMENSETZUNGEN FÜR DIABETES[2005/01]
English:COMPOSITIONS FOR DIABETES[2005/01]
French:COMPOSITIONS CONTRE LE DIABETE[2005/01]
Entry into regional phase13.09.2004Translation filed 
13.09.2004National basic fee paid 
13.09.2004Search fee paid 
13.09.2004Designation fee(s) paid 
13.09.2004Examination fee paid 
Examination procedure15.07.2003Request for preliminary examination filed
International Preliminary Examining Authority: JP
13.09.2004Amendment by applicant (claims and/or description)
13.09.2004Examination requested  [2005/01]
16.09.2010Application withdrawn by applicant  [2010/43]
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
30.03.2006Renewal fee patent year 04
29.03.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
31.03.2009Renewal fee patent year 07
24.03.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4959212  (STANCESCO ALEXANDRA [US], et al) [X] 1-9 * column 5, line 61 - column 6, line 33 * * examples 12-13 *;
 [Y]WO9804512  (IDI FARMACEUTICI SPA [IT], et al) [Y] 1-9 * the whole document *;
 [X]WO0152822  (CHOPRA RAJ K [US]) [X] 1-9 * page 3, paragraph 2 - paragraph 6 * * page 3, paragraph l - page 4, paragraph f * * page 5, line 6 - line 8 *;
 [Y]WO0217879  (CHOPRA RAJ K [US]) [Y] 1-9 * the whole document *;
 [XP]WO02090304  (KANEKA CORP [JP], et al) [XP] 1-9 * page 2, line 6 - line 15 *;
 [XP]WO02092067  (KANEKA CORP [JP], et al) [XP] 1-9 * claims 9-10 *;
 [X]  - SHIGETA Y ET AL, "Effect of coenzyme q7 treatment on blood sugar and ketone bodies of diabetics", JOURNAL OF VITAMINOLOGY 1966, (1966), vol. 12, no. 4, ISSN 0022-5398, pages 900 - 902, XP009134486 [X] 1-9 * the whole document *
 [X]  - ERIKSSON J G ET AL, "THE EFFECT OF COENZYME Q10 ADMINISTRATION ON METABOLIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS", BIOFACTORS, OXFORD UNIVERSITY PRESS, OXFORD, GB, (19990101), vol. 9, no. 2-4, ISSN 0951-6433, pages 315 - 318, XP009082244 [X] 1-9 * the whole document *
 [X]  - HENRIKSEN J E ET AL, "Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus.", DIABETIC MEDICINE : A JOURNAL OF THE BRITISH DIABETIC ASSOCIATION APR 1999 LNKD- PUBMED:10220205, (199904), vol. 16, no. 4, ISSN 0742-3071, pages 312 - 318, XP002586351 [X] 1-9 * the whole document *
 [X]  - MCCARTY M F, "Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics?", MEDICAL HYPOTHESES, (199905), vol. 52, no. 5, ISSN 0306-9877, pages 397 - 400, XP002586352 [X] 1-9 * the whole document *
 [XP]  - HODGSON J M ET AL, "Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes.", EUROPEAN JOURNAL OF CLINICAL NUTRITION, (200211), vol. 56, no. 11, ISSN 0954-3007, pages 1137 - 1142, XP002586353 [XP] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1038/SJ.EJCN.1601464
International search[X]JPS4910665B  ;
 [X]JPS5489036  (EISAI CO LTD);
 [X]JPH02249492  (LION CORP);
 [X]WO9324650  (UNIV MONASH [AU], et al);
 [X]WO9807417  (KANEKA CORP [JP], et al);
 [A]WO9841113  (SIGMA TAU IND FARMACEUTI [IT]);
 [Y]EP0882450  (KANEKA CORP [JP]);
 [XP]JP2003026567  (KANEGAFUCHI CHEMICAL IND);
 [XP]JP2003026625  (KANEGAFUCHI CHEMICAL IND);
 [XP]JP2003119126  (KANEGAFUCHI CHEMICAL IND);
 [XP]JP2003135022  (CRESCENDO CORP);
 [Y]  - Iyakuhin Yoran 5th edition 'Tsuiho Shusai-ban', OSAKA HOSPITAL PHARMACIST ASSOCIATION, (1994), pages 1614 - 1637, XP002969587
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.